Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect.
| Autor: | Srinivasan A; Internal Medicine, HCA Houston Kingwood/University of Houston College of Medicine, Kingwood, USA., Bennie B; Department of Pharmacy - Internal Medicine, HCA Houston Kingwood, Kingwood, USA., Viroliya K; Internal Medicine, HCA Houston Kingwood/University of Houston College of Medicine, Kingwood, USA., Kesavan R; Pulmonary and Critical Care - Internal Medicine, HCA Houston Kingwood/University of Houston College of Medicine, Kingwood, USA., Sarva ST; Pulmonary and Critical Care - Internal Medicine, HCA Houston Kingwood/University of Houston College of Medicine, Kingwood, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2021 May 01; Vol. 13 (5), pp. e14795. Date of Electronic Publication: 2021 May 01. |
| DOI: | 10.7759/cureus.14795 |
| Abstrakt: | In this case report, we present a patient who suffered ceftaroline-associated encephalopathy, while receiving ceftaroline for acute bacterial skin and skin structure infections (aBSSSIs) that resolved after cessation of the suspected agent. We recommend close monitoring for encephalopathy in patients with creatinine clearance (CrCl) of <50 mL/min receiving ceftaroline. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Srinivasan et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|